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Abstract
At the intersection of life sciences, materials science, engineering, and medicine, regenerative 
medicine stands out as a rapidly progressing field that aims at retaining, restoring, or augmenting 
tissue/organ functions to promote the human welfare. While the field has witnessed tremendous 
advancements over the past few decades, it still faces many challenges. For example, it has been 
difficult to visualize, monitor, and assess the functions of the engineered tissue/organ constructs, 
particularly when three-dimensional (3D) scaffolds are involved. Conventional approaches based 
on histology are invasive and therefore only convey end-point assays. The development of 
volumetric imaging techniques such as confocal and ultrasonic imaging has enabled direct 
observation of intact constructs without the need of sectioning. However, the capability of these 
techniques is often limited in terms of penetration depth and contrast. In comparison, the recently 
developed photoacoustic microscopy (PAM) has allowed us to address these issues by integrating 
optical and ultrasonic imaging to greatly reduce the effect of tissue scattering of photons with one-
way ultrasound detection while retaining the high optical absorption contrast. PAM has been 
successfully applied to a number of studies, such as observation of cell distribution, monitoring of 
vascularization, and interrogation of biomaterial degradation. In this review article, we highlight 
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recent progress in non-invasive and volumetric characterization of biomaterial-tissue interactions 
using PAM. We also discuss challenges ahead and envision future directions.
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Photoacoustic microscopy; biomedical imaging; tissue engineering; regenerative medicine; non-
invasive
Introduction
Regenerative medicine aims to create functional tissues/organs to replace those damaged or 
diseased in the body by using an interdisciplinary approach involving materials science, 
engineering, cell biology, and medicine.1 The materials, typically processed as three-
dimensional (3D) scaffolds containing well-defined structures and architecture, play a 
pivotal role in tissue regeneration by functioning as biomimetic substrates for cells to reside, 
respond, and remodel.2, 3 The scaffolds, when formed in different shapes, architecture, 
porosities, interconnectivity, and degradation profiles, can be rendered to fit for desired 
applications.2-5 Functionalization of the scaffolds with bioactive molecules further endows 
these biomimetic matrices with extended capability to precisely manipulate cellular 
behaviors for the formation of functional tissues.2, 3
In evaluating the efficacy of these approaches to promote tissue regeneration, it is necessary 
to assess a number of properties of the engineered tissue constructs, such as the viability, 
distribution, and proliferation of cells; the production/spatial arrangement of extracellular 
matrix, and degradation of the scaffold. However, it has always been a challenge to 
characterize 3D biological samples in a non-invasive and chronological manner. 
Conventional methods based on microtomy, where serial sections are obtained from a 
sample, are laborious and the capability to reconstruct the volumetric information is rather 
limited.6 In addition, the requirement of sectioning is destructive, which does not allow for 
repeated measurements of the same sample over an extended period of time. The use of 
multiple samples would increase the probability of errors originating from variations in 
scaffold and tissue fabrication. To this end, non-invasive, volumetric imaging modalities 
have clear advantages over the invasive methods.7, 8 Although many potent imaging 
technologies have been developed over the past years, limitations persist. For example, 
while pure optical imaging modules such as confocal and multi-photon microscopy can 
achieve high resolution,9 their penetration depths are usually confined to no more than a few 
hundred micrometers due to strong optical scattering of biological tissues.10 On the other 
hand, non-optical imaging modalities such as ultrasound,11 micro-computed tomography 
(micro-CT),12 magnetic resonance imaging (MRI),13 and positron emission tomography 
(PET)14 are capable of deep imaging, but they are plagued by relatively low resolution, slow 
response, and/or ionizing irradiation. None of these existing imaging techniques can meet 
the pressing needs of characterizing engineered tissues for regenerative medicine.
Photoacoustic microscopy, or PAM, is a recently developed volumetric imaging modality 
that elegantly combines optical with ultrasonic imaging to achieve both high resolution 
arising from the optical absorption contrast as well as deep penetration of up to multiple 
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millimeters due to the low scattering of acoustic waves by biological tissues.7, 15-23 Since its 
invention, PAM has been widely adopted for a variety of biomedical and medical 
applications ranging from the characterization of subcellular organelles and cells all the way 
to tissues and organs. For example, melanomas24, 25 and blood vessels16, 26 can be directly 
imaged by PAM in preclinical models without the need of external contrasts because of their 
intrinsic pigmentation, with melanin for melanoma cells and hemoglobin for erythrocytes, 
respectively. The great resolution and penetration depth of PAM have particularly rendered 
such modality useful for characterizing tissue-biomaterial interactions on the right scale.7 In 
this review, we first introduce the principle of PAM and discuss its suitability in imaging 
engineered tissue constructs. We then continue to present examples where PAM has been 
successfully applied to monitoring subcellular responses, cells, scaffolds, vasculature, and 
the interactions among these components. Finally we conclude with future perspectives on 
maximizing the utility of PAM for applications in tissue engineering or regenerative 
medicine.
Photoacoustic Microscopy
PAM relies on the optical absorption contrast to image specimens. In PAM, both the optical 
excitation and the ultrasonic detection are focused, where the foci are configured coaxially 
and confocally.17, 20 Upon illumination of an optically absorbing object with a pulsed or 
intensity-modulated laser, the transient thermoelastic expansion and contraction of the 
sample will produce acoustic waves. For each single-point laser shot, time-resolved 
ultrasonic detection produces a one-dimensional (1D), depth-resolved image. Thus, a 1D 
line scan produces a two-dimensional (2D) frame, and a 2D raster scan along the transverse 
plane generates complete 3D data. Volumetric data can be viewed through projection images 
coded by either amplitude of maximum (i.e., maximum amplitude projection, MAP) or 
depth of maximum, or direct 3D rendering. Typically, PAM can be used for imaging at a 
millimeter scale in terms of depth, together with micrometer-scale resolution. The axial 
resolution and the maximum penetration depth are dependent on the central frequency of the 
ultrasonic transducer, while the lateral resolution is predominantly determined by the tighter 
focus of the dual optical-ultrasonic foci.7, 17, 20
PAM systems commonly used for regenerative medicine applications can be classified into 
optical-resolution PAM (OR-PAM) and acoustic-resolution PAM (AR-PAM) according to 
the resolution.7, 17, 20 Figure 1a shows a schematic of OR-PAM,20, 27 where a bright-field 
optical illumination, with a much tighter focus than the acoustic focus, is adopted to achieve 
optical resolution. The pulses from the laser are focused by a microscope objective into the 
sample. The generated photoacoustic signals are detected by a focused ultrasonic transducer, 
which is placed confocally with the objective. The optical focal spot size of <5 μm is much 
smaller in diameter than the acoustic focus, so the lateral resolution is mainly determined by 
the optical focal spot size to achieve the so-called “optical resolution”. The OR-PAM 
generally has a lateral resolution finer than 5 μm, which is dependent on the optical 
wavelength and the numerical aperture (NA) of the objective,24, 27 and a penetration depth 
of up to 1.2 mm in soft tissues.27
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A schematic of AR-PAM is shown in Figure 1b.16, 20 The excitation is implemented through 
a dark-field illumination, and the light is reshaped by a conical lens to form a ring pattern. 
The ring-shaped light is then weakly focused into the sample by an optical condenser. The 
generated photoacoustic signals are detected using a focused ultrasonic transducer located in 
the center of the optical condenser. The optical and ultrasonic foci are configured coaxially 
and confocally. The optical focal spot size is on the millimeter scale in diameter, much 
larger than the ultrasonic focus, and therefore the lateral resolution is predominantly 
determined by the ultrasonic focus, the so-called “acoustic resolution”. The AR-PAM can 
achieve a lateral resolution of approximately 45 μm, an axial resolution of approximately 15 
μm, and a penetration depth of more than 3 mm in soft tissues.16
It should be noted that the light in OR-PAM may experience multiple scattering events 
before reaching the focal point in biological tissues. While the lateral resolution of PAM is 
the finest at the depth corresponding to the focus of the objective for OR-PAM or the 
ultrasonic transducer for AR-PAM, the resolution deteriorates as a function of distance away 
from the focal point. In order to maintain the high resolution of PAM over an extended 
depth range, depth scanning may further be implemented besides raster scanning at the 
expense of imaging speed.28, 29 Additionally, limited-diffracting Bessel beams can be used 
to extend the focal zone for OR-PAM,29, 30 whereas synthetic-aperture focusing technique 
based on a virtual-detector in combination with coherence weighting may be adopted for 
AR-PAM.29, 31, 32
Figure 1c graphically illustrates the correlation between the imaging depth and spatial 
resolution of PAM. The acoustic nature of photoacoustic imaging allows it to easily achieve 
a high depth-to-resolution ratio of roughly 200, constant across all PAM modalities.17, 20 
The optimal tradeoff between spatial resolution and imaging depth should depend on the 
specific application of PAM. Indeed, PAM and its extended forms, photoacoustic 
macroscopy (PAMac) and photoacoustic computed tomography (PACT),33, 34 have been 
used to probe biological structures across multiple scales,17, 20, 35 from subcellular imaging 
of individual melanosomes (Fig. 1d),24 functional imaging of individual red blood cells 
flowing in capillaries (Fig. 1e),36 and diagnosis of human skin lesions (Fig. 1f),37 all the 
way to clinical imaging of the breast vasculature in a human subject (Fig. 1g).38
While PAM provides superb contrast from optical absorption, hybrid systems integrating 
PAM with other modalities have also been constructed to increase its capability. For 
example, OR-PAM has been complemented with both fluorescence confocal microscopy 
(OR-PAM-FCM)39 and optical coherence tomography (OR-PAM-OCT).40 In OR-PAM-
FCM, a dichroic mirror and an emission filter of desired wavelength allows the transmission 
of fluorescence emitted from the sample for generating the image. The FCM subsystem has 
a lateral resolution of approximately 3.9 μm, an axial resolution of about 38 μm, and a 
penetration depth of roughly 1 mm in soft tissues.39 In OR-PAM-OCT, the OCT subsystem 
measures the depth-resolved backscattered light from the object. The OCT subsystem has a 
lateral resolution of about 5 μm and an axial resolution of about 5.9 μm in soft tissues; the 
axial imaging range of OCT is roughly 2 mm in soft tissues.40
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PAM Imaging of Cells
As the most fundamental biological component, cells actively respond to and remodel the 
local microenvironment in the development of engineered tissues. Therefore, the ability to 
characterize the cells in a tissue construct becomes a critical step towards the widespread 
applications of PAM in regenerative medicine. While early examples were demonstrated by 
the use of melanoma cells that contain natural dark pigments melanin with optical 
absorption across the visible and near infrared (NIR) regions, recent advances have also 
shifted to genetic engineering and staining by exogenous contrast agents to render 
essentially all types of cells with proper contrast mechanisms for PAM imaging.41, 42
Melanoma cells
Melanoma cells are a type of skin cancer cells that contain melanosomes with residing 
melanin, a natural dark pigment. Consequently, melanoma cells are black in color due to the 
strong optical absorption of melanin in the UV-visible-NIR regions, rendering them 
conveniently measureable by PAM.24, 25 The feasibility of non-invasive 3D imaging of 
melanoma cells in biomaterial scaffolds was initially demonstrated by us using AR-PAM.43 
The PAM coronal and sagittal MAP images in Figure 2a clearly show the distribution of 
melanoma cells in a poly(lactic-co-glycolic acid) PLGA inverse opal scaffold with a 
thickness of 1.5 mm. The volumetric data could also be directly rendered by 3D depiction 
(Fig. 2b), where individual melanoma cells or cell clusters could be mapped relative to the 
position of the scaffold. At a lateral resolution of 45 μm, it is rather fascinating to have a 
penetration depth of a few millimeters for AR-PAM, which covers the thickness range of the 
majority of the engineered tissue constructs. On the contrary, a confocal or multi-photon 
microscope could only reach a depth of several hundred micrometers at the maximum, due 
to the pronounced optical scattering by both the scaffold and the embedded cellular/
extracellular components.7
More interestingly, it has been shown that AR-PAM could further be used to temporally 
monitor and quantify cell proliferation in individual scaffolds at relatively high spatial 
resolution. Such a capacity is highly desired since conventional methods based on imaging 
multiple samples at different time points cannot retrieve information of a single construct 
over time. Figure 2c reveals time-series PAM coronal MAP images of melanoma cells in the 
same scaffold up to 14 days, where the increase in the number of cells could be readily 
observed. The volumetric data obtained using PAM was quantifiable based on the intensity 
of measured signals, and the quantification results matched those derived from the 
biochemical 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay (Fig. 2d). 
Since the laser fluence may vary during raster scanning, the absolute photoacoustic signal of 
each voxel has to be normalized against the corresponding laser fluence in order to achieve 
accurate quantification.
Genetically engineered cells
In order to achieve PAM imaging of non-pigmented cells, researchers have devised a variety 
of approaches based on genetically engineering the cells to introduce intrinsic contrast 
mechanisms. Among all, fluorescent proteins have evolved as one of the most commonly 
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used techniques for optical imaging, where cells can be engineered to express these proteins 
of desired optical properties and under different promoters to allow for functional imaging 
of subcellular events.44 While a higher quantum yield gives better imaging quality for 
optical microscopy, fluorescent proteins with lower quantum yields would elicit more 
efficient photothermal conversion that is better suited for PAM measurement.41, 42, 45 
Taking advantages of such concept, Verkhusha, Wang, and co-workers demonstrated that 
red fluorescent proteins (RFPs) with distinctive absorption peaks in the NIR region allowed 
for convenient PAM imaging (Fig. 3, a and b).46, 47 The differential absorption spectra of 
the RFP subtypes further enabled PAM with a capability to un-mix them at deep depth (Fig. 
3c). Cells expressing these RFPs could be imaged both in vitro and in vivo using PAM at 
high resolution and deep penetration depth.
More recently, researchers have developed an approach to transfect cells with genes 
encoding tyrosinase, which could oxidize tyrosine to the dark pigment melanin through a 
chain of intracellular reactions (Fig. 3d).48 In this case, the introduction of tyrosinase into 
target cells forces them to produce the absorption contrast for PAM imaging.49, 50 Unlike 
fluorescent proteins, the melanin produced by the cells has properties similar to those 
present in the melanoma cells, meaning that it possesses a constant strong absorption across 
the visible and NIR ranges (Fig. 3e).50 Both the Wang and Beard Groups showed that, HEK 
293 cells transfected with tyrosinase induced the cells to express melanin,49, 50 as revealed 
in transmission electron microscopy (TEM) images (Fig. 3f) and optical micrographs (Fig. 
3g). The 293-tyrosinase cells, when observed under PAM, exhibited strong signals 
comparable to the B16 melanoma cells, whereas the wild type cells could not be imaged 
(Fig. 3h).
The LacZ/β-galactosidase reporter gene system is another long-standing technique for 
measuring successful gene transfection.51 Cells carrying such reporter gene will produce β-
galactosidase, which catalyzes the hydrolysis of 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) into galactose and 5-bromo-4-chloro-3-hydroxyindole; the latter 
molecule then spontaneously dimerizes and is subsequently oxidized into 5,5′-dibromo-4,4′-
dichloro-indigo, a blue precipitate that is water insoluble (Fig. 3i).52 The 5,5′-dibromo-4,4′-
dichloro-indigo has a strong absorption in the visible light regime that is distinctive from 
that of the blood (Fig. 3j),53, 54 consequently allowing for efficient PAM imaging. Figure 3k 
shows an OR-PAM image and an optical image of the 9L/LacZ glioblastoma cells stained 
with X-gal.55 After staining the blue precipitations of 5,5′-dibromo-4,45′-dichloro-indigo 
were clearly discernible under PAM. Although X-gal is the most commonly used substrate 
for β-galactosidase, there are many variants that produce other colors after hydrolysis, such 
as 5-bromo-3-indolyl-β-D-galactopyranoside (dark blue), N-methylindolyl-β-D-
galactopyranoside (green), 6-chloro-3-indolyl-β-D-galactopyranoside (pink), 5-bromo-6-
chloro-3-indolyl-β-D-glucopyranoside (magenta), and 5-iodo-3-indolyl-β-D-
galactopyranoside (purple).52 These different substrates potentially enable a greater choice 
over the spectral regions in which PAM can be used for imaging cells engineered with the 
LacZ reporter system.
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Contrast agent-stained cells
Contrast enhancement enabled by chemical staining has also been widely adopted for PAM 
imaging of cells and subcellular structures.41, 42 Comparing to genetic engineering, 
approaches based on exogenous contrast agents are in general faster and more conveniently 
available to researchers. To this end, several contrasting mechanisms based on chemicals 
and nanoparticles have been adopted and demonstrated.
We demonstrated that, MTT, a tetrazole that is reduced to MTT formazan in living cells, 
could be used as a strong contrast agent for PAM.56 The MTT assay has long been used to 
biochemically evaluate the metabolic activity of cells.57 The MTT is water-soluble and has a 
yellowish color only with absorption below 450 nm. By contrast, MTT formazan is 
insoluble in water; the crystals have a strong absorption in the spectral region of 500–700 
nm and a peak at around 650 nm. As a result, the formazan generated inside living cells can 
be directly used to enhance their contrast for PAM, where the crystals functions as an 
equivalent to the natural pigments in melanoma cells.56
Using MTT formazan as a contrast agent, we have successfully demonstrated that non-
pigmented cells could be imaged under PAM at a contrast proportional to the amount of 
formazan formed inside the cells.56 It was found that, such staining method is universal, and 
can be applied to all cell types that are metabolically active. We further proved the 
feasibility of PAM for 3D imaging of cells after staining with MTT formazan. As shown in 
Figure 4a, AR-PAM could obtain volumetric information of the distribution of MC3T3 
preosteoblasts cultured in an inverse opal scaffold after 3 h of incubation in a medium 
containing 5 mg/mL MTT, with the capability of 3D rendering (Fig. 4b), indicating the 
efficacy of the contrast provided by MTT formazan. Even when embedded in an alginate 
hydrogel inside a scaffold, MTT molecules could still diffuse and stain the cells (Fig. 4c). 
Comparison between PAM and optical microscopy images clearly showed matching 
features between the two (Fig. 4d). Again, the proliferation of the cells inside a scaffold was 
quantifiable, and comparable to the biochemical MTT analysis (Fig. 4, e and f). A cell 
invasion assay was further performed, where inward proliferation of cells from the surface 
of the inverse opal scaffolds could be observed (Fig. 4g). With the non-invasively 
quantification of cell migration depth using PAM, the differential rates of cell migration into 
the scaffolds with two set of pore sizes could be calculated (Fig. 4h).
Besides MTT formazan, it should be noted that other tetrazolium-formazan systems, which 
possess absorption peaks covering spectral ranges different from MTT formazan, could also 
be used.57 Together, these various tetrazolium-formazan systems will potentially enable 
multi-wavelength imaging of cells and engineered biological structures by PAM.
Another strategy for staining the cells for PAM imaging is based on the chromogenic 
(immune)cytochemistry. Although such a staining method has been used as a pivotal tool for 
cell biology, pathology, and medicine for a century, its capacity is limited by the 
conventional optical microscopy in that only a very thin layer of tissues, typically in the 
sub-10-μm thickness, can be examined at a time. Consequently, the traditional histological 
analysis not only is laborious but also does not allow for convenient reconstruction of the 
volumetric data,6 which is preferred in most cases. Realizing the rich absorption contrasts 
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present in the biological samples after histochemical staining, we have successfully 
extended its application to PAM imaging of cells in 3D scaffolds without any need of 
physical sectioning.58 As shown in Figure 5, a–c, after the MT3T3 cells in a PLGA inverse 
opal scaffold had been stained for f-actin sequentially with biotin-phalloidin, streptavidin-
horseradish peroxidase (HRP), and diaminobenzidine (DAB) peroxidase substrate, they 
became readily visible under both conventional bright-field optical microscopy and OR-
PAM. As expected, the optical microscope could only image the cells at the top surface of 
the scaffold and one had to section the scaffold into slices in order to observe the cells in the 
pores beneath (Fig. 5a). On the contrary, the stained cells in multiple layers of the pores in 
the scaffold were well discernible at single-cell resolution under OR-PAM (Fig. 5, b and c). 
The volumetric information gathered from PAM further allowed for optical sectioning of the 
scaffold and observation of the cells at any selected depth (Fig. 5c).
Interestingly, just like histological staining, PAM is also capable of imaging multiple cell 
types co-cultured in the same scaffold, thanks to the development of peroxidase substrates 
that generate precipitation products of different colors, such as ImmPACT™ DAB (brown), 
ImmPACT™ NovaRed/AEC (red), ImmPAC™ VIP (purple), and Vector® SG (blue/
gray).59 By taking advantages of the distinctive absorption spectra of these chromogenic 
agents, PAM can be used to achieve spectral un-mixing through scanning a sample at 
carefully chosen wavelengths. In one example, MC3T3 preosteoblasts and SK-BR-3 breast 
cancer cells were mixed and seeded onto an inverse opal scaffold, after which the cells 
underwent a dual-color staining procedure.58 The f-actin of both types of cells was stained 
in brown with biotin-phalloidin, streptavidin-HRP, and DAB, whereas the human epidermal 
growth factor receptor 2 (HER2) on the surface of the SK-BR-3 cells were stained in red by 
biotin-anti-HER2 antibody, streptavidin-HRP, and the NovaRED peroxidase substrate. It 
was found that, the product of DAB/HRP had a distinct absorption peak centered at 
approximately 500 nm, with both products of DAB/HRP and NovaRED/HRP showing 
similar absorptions at >570 nm. Using a dual-wavelength scanning at 523 nm and 570 nm, 
PAM could digitally separate the two cell populations in the scaffold with individual SK-
BR-3 cells distinguishable (Fig. 5, d and e). Spatial distribution of the SK-BR-3 cells across 
the entire MC3T3-coated scaffold was also available through the volumetric PAM data (Fig. 
5e, bottom panel).
It was further shown that, the conventional histology methods relying on non-specific 
staining also power PAM imaging.58 For example, hematoxylin and eosin (H&E) that stain 
cell nuclei blue and cytoplasm pink, respectively, allow for convenient PAM differentiation 
of the two subcellular components; the Masson's Trichrome staining that renders 
erythrocytes red, cytoplasm/muscle pinkish purple, and collagen blue endows PAM the 
capability to not only spectrally un-mix these components but also quantify their area 
percentages. In a sense, PAM has significantly increased the capacity of the conventional 
histology and immunohistochemistry by adding a third dimension to imaging the stained 
specimens. The volumetric imaging of absorption-rich biological structures provided by 
PAM essentially eliminates the need of physically sectioning, thus maintaining the integrity 
of the samples and simultaneously reducing the labor involved in the process.
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Besides staining based on chemicals, cells have also been efficiently labeled by 
nanoparticles to enhance their contrasts for PAM imaging. For example, Emelianov and co-
workers have demonstrated that human mesenchymal stem cells (hMSCs) could uptake Au 
nanoparticles when they were incubated together.60 The labeled hMSCs were then 
longitudinally monitored using ultrasound-guided PAM imaging both in vitro in a hydrogel 
phantom and in vivo in a rat intramuscular hind limb model for up to 7 days. Similarly, we 
have demonstrated that Au nanocages (AuNCs) could also serve as a strong contrast-
enhancing agent for PAM imaging owing to their large optical cross-sections.61, 62 When 
hMSCs were labeled with AuNCs, they could be readily detected by PAM both in vitro and 
in vivo.63 The homing of such labeled hMSCs to the tumor region in a mouse model was 
subsequently monitored in vivo using OR-PAM. It was found that the uptake of AuNCs by 
the hMSCs did not decrease the viability of the cells nor alter their differentiation potential 
into multiple lineages, indicating that these contrast agents are superb candidates for PAM 
tracking of cells.
PAM Imaging of Scaffolds
Scaffolds are equally important as the cellular components in engineering functional tissues 
since they not only provide structural/mechanical supports to mold the tissues but also 
constitute the substrates to incorporate bioactive molecules for residing cells or invading 
tissues to respond.2-4 In fact, characterizing the tissue constructs has been focused on ways 
to image the cells and tissues, and rarely has it been reported for the assessment of the 
matrices in a non-invasive manner. With the development of imaging techniques, 
biomedical engineers are starting to adopt advanced imaging modalities for investigating the 
properties of the scaffolds instead of the conventional invasive mass loss assessments.8 For 
example, using fluorescently labeled hydrogels composed of poly(ethylene glycol) (PEG)-
dextran, Edelman and colleagues were able to follow the material loss of the same scaffolds 
by fluorescence imaging.64 Nonetheless, this pure optical method inevitably presented a 
limited resolution at the millimeter scale, thus rendering the fine structures of the scaffold 
undiscernible. Alternative approaches relying on ultrasonic imaging11 and X-ray CT8, 12 
have also been developed, but both of them suffer from insufficient resolution and/or 
contrast. Therefore, PAM, with an elegant combination of optical and ultrasonic imaging, 
has become an enabling modality to characterize the scaffolds.
Since most biomaterials themselves do not possess strong optical absorption, contrast 
mechanisms typically need to be incorporated into the scaffolds prior to PAM imaging. To 
this end, single-walled carbon nanotubes (SWCNTs) have been incorporated into PLGA 
inverse opal scaffolds to enhance their absorption contrast.65, 66 Using OR-PAM, Wang, 
Sitharaman, and co-workers quantified the average porosity and pore size of the scaffolds at 
a 2.6-μm lateral resolution, whereas AR-PAM further extended the tissue penetration to 
deeper than 2 mm at slightly reduced resolution of 45 μm. Building upon this work, we have 
doped PLGA inverse opal scaffolds with the more biocompatible MTT formazan as a 
contrast agent, and investigated the degradation of such scaffolds with respect to two 
different media: phosphate buffered saline (PBS) and the more physiologically simulating 
body fluid, PBS supplemented with lipase. Using the OR-PAM, the fine structures of the 
scaffolds with a thickness of 2 mm could be clearly observed in depth-coded MAP images 
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(Fig. 6, a–d and e–h). As expected, when incubated in pure PBS without any supplements, 
the PLGA scaffold did not show signification alteration in morphology over the 6-week 
period tested (Fig. 6, a–d). In comparison, the scaffold immersed in a microenvironment 
containing lipase completely degraded by the end of 6 weeks (Fig. 6, e–h), indicating the 
cleavage of the ester unit in the PLGA backbone by the lipase. Magnified PAM images 
further revealed the superior resolution of the OR-PAM system, where individual pores and 
even the windows interconnecting adjacent pores in the scaffold were clearly visible (Fig. 6, 
i–l). AR-PAM was then used to quantitatively assess the degradation profiles of the 
scaffolds. It was found that the scaffolds degraded by 40% and 90%, respectively, in the two 
types of media as calculated from the PAM volumetric data. The quantification results 
obtained using PAM correlated well with those measured from similar scaffolds using the 
invasive mass loss assay. More recently, Pérez-Juste and co-workers doped poly(N-
isopropylacrylamide) microgels with Au nanorods to significantly increase the absorption 
contrast of the hydrogel scaffolds, potentially rendering them visible under PAM.67
PAM Imaging of Vasculature
Blood vessels play a critical role in maintaining the viability and functionality of engineered 
tissues by transporting oxygen, nutrients, and wastes to and away from the tissues.68 
Nonetheless, it remains a challenge to non-invasively monitor and measure the development 
of the neovasculature inside the tissue constructs over time at high resolution and deep 
penetration. The most widely used imaging modalities for assessing the neovascularization 
process in implanted scaffolds include micro-CT69 and confocal/two-photon microscopy.70 
Both of these modalities, require the administration of exogenous contrast agents, in 
addition to the ionizing irradiation caused by X-ray and the insufficient penetration depth 
offered by the optical methods. PAM, on the other hand, is well suited for performing this 
task. As discussed before, hemoglobin exhibits strong intrinsic optical absorption spanning 
across the entire UV-visible-NIR range,7, 16, 17, 20, 26, 27, 33, 71 making it readily measurable 
by PAM.
We have demonstrated the capability of PAM to monitor the infiltration of blood vessels 
into 3D porous scaffolds.72 We fabricated PLGA inverse opal scaffolds of two sets of 
uniform sizes, 200 μm and 80 μm, respectively, and implanted them in a mouse ear model. 
Using AR-PAM, we successfully monitored the development of neovasculature from the 
surrounding tissues into the same scaffolds without the need to sacrifice the animals, at 
single-vessel resolution and >3 mm imaging depth. Figure 7, a–d and e–h, shows PAM 
coronal/sagittal MAP images taken at Weeks 1, 2, 4, and 6 for the two types of scaffolds, 
respectively. By comparing the two groups of images, distinct patterns of neovascularization 
could be observed: the scaffold with larger pores induced higher degree of 
neovascularization than that with smaller pores, particularly at later stages of implantation. 
Such a difference could further be quantified using the PAM volumetric data, where the 
vessels in the scaffolds with 200-μm pores had more than twice total areas of those in the 
scaffolds with 80-μm pores (Fig. 7, i and j). Two parallel groups of animals bearing the same 
scaffolds were subjected to histology to measure the blood vessel ingrowth into the 
scaffolds, and the results obtained from these invasive assessments matched well with the 
non-invasive PAM quantifications (Fig. 7, i and j). Because of the optical sectioning 
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capability, the areas of infiltrating blood vessel at the surface versus the center of the two 
types of scaffolds could be further analyzed for the PAM data, which again, were similar to 
those calculated from the physical histology sections (Fig. 7k). In all quantification results, 
the area of blood vessels at each time point was normalized against that of the scaffold with 
a pore size of 80 μm at Week 2.
The PAM imaging of neovascularization in engineered tissues could potentially replace the 
conventional histology assays, especially when long-term monitoring of the same implants 
is needed. Indeed, the invasive histology analyses not only require sacrifice of multiple 
animals at each time point, but more labor-intensively involve additional sectioning and 
staining procedures to mark the blood vessels for subsequent measurements. The variations 
in the scaffolds themselves might potentially alter the pattern of neovascularization as well. 
By contrast, the few animals can be monitored longitudinally using PAM due to its non-
invasive nature, rendering the analyses more accurate for the individual scaffolds of interest.
Interestingly, a number of groups have demonstrated that some lipids present in the vessel 
walls could also be detected using PAM or its macroscopic variants due to the absorption of 
these chemical species in the NIR region (approximately 1200–1800 nm).73-76 The ability of 
PAM to image the lipid-rich plaques in blood vessels provides a convenient approach to 
non-invasive detection of vascular malfunctions such as arteriosclerosis and coronary artery 
diseases.
Probing Scaffold-Tissue Interactions with PAM
A rational extension of the applications of PAM in regenerative medicine discussed above 
should naturally converge to a stage where both the biological component and scaffold can 
be monitored simultaneously. This concept has spurred the utilization of PAM in probing 
the scaffold-tissue interactions in a non-invasive manner. By doping PLGA inverse opal 
scaffolds with MTT formazan, followed by implantation of the scaffolds in a mouse ear 
model, we could monitor the degradation of individual scaffolds in vivo by AR-PAM for 
weeks without sacrificing the animal (Fig. 8, a–d).77 The main body of the scaffold reduced 
its size over time, with small pieces falling off, gradually disappearing, and being uptaken 
by the vasculature. It should be noted that, at the scanning wavelength of 638 nm, only the 
scaffold was visible while the interference from the blood vessels was minimized due to the 
relatively weaker absorption of hemoglobin compared to MTT formazan at this wavelength. 
The quantitative data derived from PAM imaging was similar to those obtained using the 
conventional destructive, mass-loss assessment (Fig. 8e), indicating the accuracy of the 
imaging approach. When switched to 578 nm, on the other hand, we were able to acquire 
images of both the scaffold and vasculature because both hemoglobin and MTT formazan 
have strong absorptions at this wavelength. After subtracting the signals from the scaffold, 
the blood vessel component could be singled out with a minimal interference from the 
scaffold. Figure 8, f–i, shows co-registered 3D depictions of the blood vessels (red) and the 
scaffold (green) at Weeks 0, 1, 3, and 6 post implantation. The degradation of the scaffold 
and the remodeling of blood vessels could be identified at the same time from these images. 
The corresponding cross-sectional images in Figure 8, j–m, further revealed the decrease in 
thickness and diameter for the scaffold with hints of infiltrating blood vessels into the 
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interior of the scaffold from the surrounding. The thickness of the scaffold decreased from 
about 1.5 mm at Week 0 to roughly 0.8 mm at Week 6, and some blood vessels were 
observed to develop into the void space of the scaffold.
PAM characterization of the scaffold-tissue interactions can also benefit from a multi-
modality platform. For example, the aforementioned OR-PAM-FCM hybrid system39 has 
been used to interrogate the behaviors of cells inside biomaterial scaffolds (unpublished 
data). When the scaffold is stained with a fluorescence probe such as rhodamine, it could be 
well resolved through the use of FCM subsystem (Fig. 9a). When seeded with melanoma 
cells, OR-PAM-FCM could be effectively used to monitor the proliferation and migration of 
cells in relation to the pores of the scaffold over a period of 7 days (Fig. 9, b and c).
The OR-PAM-OCT hybrid system is another great candidate.40 While PAM images cells 
and tissues at high resolution and strong absorption contrast, the OCT subsystem, on the 
other hand, could resolve the structures of the polymeric scaffolds in a label-free manner due 
to the strong optical scattering contrast provided by the mismatching refractive indices of the 
biomaterial and the surrounding medium. Using OCT, it is unnecessary to further stain the 
scaffolds with exogenous contrast agents, thus minimizing potential modification to their 
properties caused by the doping process. In one demonstration, we cultured melanoma cells 
on a PLGA inverse opal scaffold and monitored the behaviors of the cells over a course of 6 
days (unpublished data). As indicated in Figure 9d, the proliferation and inward migration of 
the melanoma cells could be observed using OR-PAM-OCT at a resolution of <5 μm. In 
addition, both the PAM and OCT subsystems could achieve a deep penetration depth of 
approximately 1 mm, spanning across the entire thickness of the scaffold (Fig. 9e). The 
volumetric data could also be 3D-rendered to reveal the spatial distribution of cells in the 
scaffold (Fig. 9f).
Furthermore, OR-PAM-OCT has been demonstrated for its capability in simultaneously 
imaging the vasculature and scaffold in vivo.72 Figure 10, a–c and d–f, shows the 
development of vasculature in a mouse ear surrounding the implant and the morphological 
changes to the scaffold for 6 weeks. The arrowheads in Figure 10, d–f, indicate the 
expansion of the pores in the scaffold potentially due to its degradation. Superimposed 
cross-sectional images and 3D reconstruction views further revealed the invasion of blood 
vessels from the surface into the pores in the scaffold (Fig. 10, g–i), reaching a depth of >1 
mm by the end of Week 6 (Fig. 10i).
Perspective
While a significant progress has been made in demonstrating the unique application of PAM 
for characterizing engineered tissue constructs, more systematic investigations are still 
needed before we can take full advantage of the functional imaging capacity of PAM. For 
example, interactions among multiple cell types inside a scaffold can be performed by 
genetically engineering the cells to express chromoproteins of different absorption spectra.78 
A step further, animals can be engineered to render specific cell populations with desired 
optical absorptions, allowing for direct observation of the host responses to an implant. 
Additionally, PAM can measure the flow rate (via the Doppler flowmetry79) and the 
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metabolic activity in blood (based on the differential absorption properties of 
oxyhemoglobin [HbO2] and deoxyhemoglobin [Hb]26, 35, 71) in a label-free manner, 
revealing not only the morphology but also the functions of the vasculature developed in the 
scaffolds. With further advancement in the instrumentation of PAM systems and integration 
with state-of-the-art sample preparation techniques (e.g., CLARITY,80 and expansion 
microscopy81), we believe that it will emerge as one of the standard imaging modalities for 
biomedical engineers who are particularly interested in applications related to regenerative 
medicine.
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Figure 1. 
(a, b) Schematic illustrations of (a) OR-PAM and (b) AR-PAM, respectively. (c) Imaging 
depth versus spatial resolution for PAM. SM, submicrometer; LA, linear array. (d–g) Multi-
scale PAM images of organelles, cells, tissues, and organs in vivo: (d) subwavelength PAM 
of melanosomes in the ear of a black mouse; (e) OR-PAM of individual red blood cells 
traveling along a capillary in a mouse ear; (f) AR-PAM of a nevus on a human forearm; and 
(g) PACT of vasculature in a human breast. Adapted with permission from Ref.20, copyright 
2012 American Association for the Advancement of Science.
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Figure 2. 
(a) PAM coronal (top) and sagittal (side) MAP images. The black dots or patches 
correspond to melanoma cells. (b) A 3D reconstruction image, where the contour of the 
scaffold is marked by dotted lines. (c) Time course PAM images (coronal MAP of the entire 
volume) of melanoma cells in a typical PLGA inverse opal scaffold at 1, 3, 7, and 14 days 
post-seeding. (d) Quantitative analysis of melanoma cells in scaffolds derived from both the 
PAM volumetric data and the MTT assay. Adapted with permission from Ref.43, copyright 
2010 Elsevier.
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Figure 3. 
(a) Overlay of the molar extinction spectra of iRFP670, iRFP720, HbO2, and Hb. (b) 
Photoacoustic signal amplitudes of equal amounts of purified fluorescent proteins 
(mNeptune, E2-Crimson, eqRFP670, iRFP670, iRFP713, iRFP720) at the four indicated 
wavelengths. (c) PAM images of tubes containing lysed blood and equal concentrations of 
purified iRFP670 and iRFP720, unmixed at different depths (0, 0.9, and 1.9 mm) of overlaid 
tissue. Adapted with permission from Ref.47, copyright 2014 Nature Publishing Group. (d) 
Schematic showing tyrosinase-induced melanin synthesis pathway. (e) Photoacoustic 
spectroscopy of tyrosinase (Tyr)-expressing cells. (c) Pigmented cytoplasmic granules in 
cells expressing Tyr observed by TEM: native (left) and Tyr-expressing cells (right). 
Adapted with permission from Ref.50, copyright 2014 Nature Publishing Group. (g) 
Photograph of melanin production in wild-type (293-wt), and Try-transfected (293-TYR) 
cells. (h) Photograph and normalized photoacoustic results of tube phantom showing blood 
in red and melanin in green. Adapted with permission from Ref.49, copyright 2011 
International Society for Optics and Photonics. (i) Schematic diagram showing the X-gal/
galactosidase reaction. (j) Comparison of absorption spectra for the blue product, HbO2, and 
Hb. Adapted with permission from Ref.53, copyright 2007 International Society for Optics 
and Photonics. (k) OR-PAM MAP image and photograph showing 9L/lacZ cells stained 
with X-gal. nu: cell nucleus. Scale bars: 10 μm. Adapted with permission from Ref.55, 
copyright 2012 Public Library of Science.
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Figure 4. 
(a) PAM MAP image of fibroblasts cultured in an inverse opal scaffold, followed by MTT 
staining; (b) 3D rendering of the volumetric PAM data in (a). (c) PAM MAP image of 
fibroblasts cultured in an inverse opal scaffold filled with cross-linked alginate hydrogel, 
followed by incubation with MTT; (d) an optical micrograph showing the same scaffold as 
in (c). The arrows indicate the matching features in PAM and optical microscopy. (e) PAM 
chronological images of fibroblasts grown in inverse opal scaffolds at 6 h, 3 days, and 7 
days; (f) quantification of cell numbers in the scaffolds as determined by volumetric PAM 
data and parallel MTT biochemical assays. (g) PAM sagittal MAP images showing cell 
invasion profiles at Days 1 and 7 into inverse opal scaffolds with a pore size of 300 μm; (h) 
quantification of average cell penetration depths in scaffolds with pore sizes of 200 and 300 
μm, respectively, as determined by PAM virtual biopsy. Adapted with permission from 
Ref.56, copyright 2011 Wiley-VCH.
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Figure 5. 
(a) A transmission optical micrograph showing the cells cultured in an inverse opal scaffold 
for 3 days and stained with biotin-phalloidin/HRP-streptavidin/DAB. (b) OR-PAM MAP 
image of the same cell/scaffold construct in (a). (c) OR-PAM image showing the bottom 
section (100–200 μm beneath the top surface) of the surface pores in the scaffold. (d) OR-
PAM MAP image of a co-culture of SK-BR-3 (stained for HER2 antigen with HRP/
NovaRed) and MC3T3 preosteoblasts (stained for f-actin with HRP/DAB), where the two 
cell types could be digitally separated in the image using spectral un-mixing. (e) Magnified 
views of the same sample showing volumetric distribution of the two cell types from the top 
and side, respectively. Reprinted with permission from Ref.58, copyright 2014 Wiley-VCH.
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Figure 6. 
(a–h) OR-PAM coronal projection images showing the degradation of a PLGA inverse opal 
scaffold immersed in (a–d) plain PBS and (e–h) PBS containing 0.025 wt.% lipase at 37 °C 
for a period up to 6 weeks. (i–l) Magnified views showing the top-left corner of the images 
in (e– h), respectively. While the scaffold in PBS did not undergo obvious structural 
alterations for up to Week 6, the scaffold showed remarkable changes over time in the 
presence of lipase. The images are color-coded by depth of maximum. Reprinted with 
permission from Ref.77, copyright 2014 Wiley-VCH.
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Figure 7. 
(a–d) Top panel: MAP images showing the remodeling of neovasculature in a scaffold with 
a pore size of 200 μm at 1, 2, 4, and 6 weeks post implantation in a mouse ear model. 
Bottom panel: the corresponding cross-sectional images at planes marked by the green 
dashed lines. (e–h) Top panel: MAP images showing the remodeling of neovasculature in a 
scaffold with a pore size of 80 μm at 1, 2, 4, and 6 weeks post-implantation. Bottom panel: 
the corresponding cross-sectional images at planes marked by the green dashed lines. The 
square indicates the area where the scaffold resided. (i, j) Normalized blood vessel area 
calculated from both PAM data and histology for scaffolds with pore sizes of 200 μm and 80 
μm, respectively. (k) Comparison of the blood vessel area in the scaffolds at planes close to 
the surface and in the central region of the scaffolds at 6 weeks post implantation. S: surface; 
C: center; His: histology. In (i–k) the area of blood vessels at each time point was 
normalized against that of the scaffold with a pore size of 80 μm at week 2. Reprinted with 
permission from Ref.72, copyright 2011 Mary Ann Liebert, Inc.
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Figure 8. 
(a–d) AR-PAM coronal MAP images taken from the same PLGA inverse opal scaffold 
implanted in the ear of a nude mouse at weeks 0, 1, 3, and 6 post implantation, respectively. 
The arrowheads indicate small pieces of the scaffold that likely came off during the surgery, 
and their slight changes in position and orientation relative to the main scaffold at different 
time points could be attributed to the activity of the mouse. (e) Comparison of the 
degradation profiles of scaffolds as a function of time obtained from the same scaffold using 
PAM and from different scaffolds using the conventional invasive mass loss assay. (f–i) Co-
registered 3D reconstruction images showing both the degradation of the same scaffold and 
the remodeling of vasculature simultaneously. (j–m) Co-registered B-scan images at the 
dotted planes as indicated in (f–i), respectively. Reprinted with permission from Ref.77, 
copyright 2014 Wiley-VCH.
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Figure 9. 
(a) FCM imaging of a fluorescently labeled PLGA inverse opal scaffold using an OR-PAM-
FCM hybrid system. (b, c) OR-PAM-FCM monitoring of melanoma cells grown on the 
scaffold, where the cells and scaffold were imaged using the PAM and FCM subsystems, 
respectively. OR-PAM-OCT images of melanoma cells cultured on an individual PLGA 
inverse opal scaffold for up to 6 days. (d, e) Coronal and sagittal views of the PAM and 
PAM/OCT images showing the ingrowth of melanoma cells from the surface into the center 
of the scaffold using the OR-PAM-OCT hybrid system. The melanoma cells were imaged 
by the PAM subsystem whereas the scaffold by the OCT subsystem in a label-free manner. 
(f) Volumetric rendering of the OCT-imaged scaffold (gray) with PAM-detected melanoma 
cells (red).
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Figure 10. 
(a–c) MAP PAM images showing the development of blood vessels into an inverse opal 
scaffold with a pore size of 200 μm at 2, 4, and 6 weeks, respectively, post implantation in a 
mouse ear model. (d–f) The corresponding OCT MAP images showing the scaffold/tissue 
construct. The signals from the skin layer were removed from all the OCT images to show 
the surface of the scaffold more clearly. Arrowheads indicate examples of local increase in 
pore size over time due to degradation of the scaffold. (g–i) Co-registered cross-sectional 
views and 3D depictions of the vasculature (red) and scaffold/tissue construct (green) at 2, 4, 
and 6 weeks, respectively, post-implantation. The arrowheads indicate the growth of 
neovasculature into the pores of the scaffold. Reprinted with permission from Ref.72, 
copyright 2011 Mary Ann Liebert, Inc.
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